CONCLUSION WITH SUCCESS THE COLLECTION OF THE CONVERTIBLE OBLIGATORY PRESTIGE
Health Italia S.p.A., the innovative SME quoted on the AIM Italia market and one of the biggest independent realities of the Italian integrated health market, advises that, as of today’s date, the placement of the bond loan entitled “HI 2018-2023” has closed.
As part of the placement 200 convertible shares were subscribed for a total amount equal to 10 million euros.
The starting price of the bonds was fixed at 7,634 euros which was calculated by applying a premium of 50% to the average weighted price of Health Italia shares on the five days prior to the closure of the placement.
The bonds will have a duration of 5 years and an annual fixed interest rate of 4.50%.
For further information, please refer to the press release of March 18th, 2018.
The purpose of the convertible bonds issue was to attain revenue to be allocated for the development of the activities provided for in the 2018-2020 Industrial Plan decided on December 28th, 2017 which foresees an increase of income up to 60 million euros and an EDITBA greater than 30%.
Company President Roberto Anzanello announced, “we are satisfied that the bond loan found favour with investors as a qualifying element for carrying out our 2018-2020 Industrial Plan and we have a clear route to follow in order to reach our outlined objectives.”
Health Italia was followed in the operation by Mediobanca – Banca di Credito Finanziario, as Financial Advisor and Sole Bookrunner,by the law firm Osborne Clarke, in the person of Umberto Piattelli as the legal advisor and by Dr. Giovanni Frosio of the Studio Professionale Commercialisti Associati.
